Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 238

1.

Quality of Life Following Major Laparoscopic or Open Pancreatic Resection.

Torphy RJ, Chapman BC, Friedman C, Nguyen C, Bartsch CG, Meguid C, Ahrendt SA, McCarter MD, Del Chiaro M, Schulick RD, Edil BH, Gleisner A.

Ann Surg Oncol. 2019 Jun 21. doi: 10.1245/s10434-019-07449-x. [Epub ahead of print]

PMID:
31228131
2.

Surgical Outcomes After Pancreatic Resection of Screening-Detected Lesions in Individuals at High Risk for Developing Pancreatic Cancer.

Canto MI, Kerdsirichairat T, Yeo CJ, Hruban RH, Shin EJ, Almario JA, Blackford A, Ford M, Klein AP, Javed AA, Lennon AM, Zaheer A, Kamel IR, Fishman EK, Burkhart R, He J, Makary M, Weiss MJ, Schulick RD, Goggins MG, Wolfgang CL.

J Gastrointest Surg. 2019 Jun 13. doi: 10.1007/s11605-019-04230-z. [Epub ahead of print]

PMID:
31197699
3.

Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation Combination.

Lennon S, Oweida A, Milner D, Phan AV, Bhatia S, Van Court B, Darragh L, Mueller AC, Raben D, Martínez-Torrecuadrada JL, Pitts TM, Somerset H, Jordan KR, Hansen KC, Williams J, Messersmith WA, Schulick RD, Owens P, Goodman KA, Karam SD.

Clin Cancer Res. 2019 Jun 1;25(11):3352-3365. doi: 10.1158/1078-0432.CCR-18-2811. Epub 2019 Apr 3.

PMID:
30944125
4.

CD28H expression identifies resident memory CD8 + T cells with less cytotoxicity in human peripheral tissues and cancers.

Tian Y, Sun Y, Gao F, Koenig MR, Sunderland A, Fujiwara Y, Torphy RJ, Chen L, Edil BH, Schulick RD, Zhu Y.

Oncoimmunology. 2018 Nov 5;8(2):e1538440. doi: 10.1080/2162402X.2018.1538440. eCollection 2019.

PMID:
30713797
5.

Recurrent Solid Pseudopapillary Neoplasm of Pancreas: Case Report and Review of Literature.

Sharma PK, Mehrotra S, Gleisner AL, Schulick RD, McCarter MD.

J Pancreat Cancer. 2018 Jun 1;4(1):25-29. doi: 10.1089/pancan.2018.0006. eCollection 2018.

6.

Use of Total Pancreatectomy and Preoperative Radiotherapy in Patients Undergoing Pancreatectomy with Artery Resection.

Del Chiaro M, Schulick RD.

J Am Coll Surg. 2019 Jan;228(1):131. doi: 10.1016/j.jamcollsurg.2018.10.016. No abstract available.

PMID:
30580801
7.

Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity.

Fujiwara Y, Sun Y, Torphy RJ, He J, Yanaga K, Edil BH, Schulick RD, Zhu Y.

Cancer Res. 2018 Dec 1;78(23):6655-6665. doi: 10.1158/0008-5472.CAN-18-1781. Epub 2018 Oct 12.

PMID:
30315115
8.

Microfluidics contrasted to thrombelastography: perplexities in defining hypercoagulability.

Lawson PJ, Moore HB, Moore EE, Gerich ME, Stettler GR, Banerjee A, Schulick RD, Nydam TL.

J Surg Res. 2018 Nov;231:54-61. doi: 10.1016/j.jss.2018.04.059. Epub 2018 Jun 8.

9.

Immunotherapy for pancreatic cancer: Barriers and breakthroughs.

Torphy RJ, Zhu Y, Schulick RD.

Ann Gastroenterol Surg. 2018 Jun 22;2(4):274-281. doi: 10.1002/ags3.12176. eCollection 2018 Jul. Review.

10.

Perioperative and Survival Outcomes Following Neoadjuvant FOLFIRINOX versus Gemcitabine Abraxane in Patients with Pancreatic Adenocarcinoma.

Chapman BC, Gleisner A, Rigg D, Messersmith W, Paniccia A, Meguid C, Gajdos C, McCarter MD, Schulick RD, Edil BH.

JOP. 2018 Mar;19(2):75-85. Epub 2018 Mar 30.

11.

Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.

Canto MI, Almario JA, Schulick RD, Yeo CJ, Klein A, Blackford A, Shin EJ, Sanyal A, Yenokyan G, Lennon AM, Kamel IR, Fishman EK, Wolfgang C, Weiss M, Hruban RH, Goggins M.

Gastroenterology. 2018 Sep;155(3):740-751.e2. doi: 10.1053/j.gastro.2018.05.035. Epub 2018 May 24.

PMID:
29803839
12.

Comparing Short-term and Oncologic Outcomes of Minimally Invasive Versus Open Pancreaticoduodenectomy Across Low and High Volume Centers.

Torphy RJ, Friedman C, Halpern A, Chapman BC, Ahrendt SS, McCarter MM, Edil BH, Schulick RD, Gleisner A.

Ann Surg. 2018 May 16. doi: 10.1097/SLA.0000000000002810. [Epub ahead of print]

PMID:
29771723
13.

Utility of Viscoelastic Assays Beyond Coagulation: Can Preoperative Thrombelastography Indices Predict Tumor Histology, Nodal Disease, and Resectability in Patients Undergoing Pancreatectomy?

Moore HB, Paniccia A, Lawson PJ, Torphy RJ, Nydam TL, Moore EE, McCarter MD, Schulick RD, Edil BH.

J Am Coll Surg. 2018 Jul;227(1):55-62. doi: 10.1016/j.jamcollsurg.2018.03.031. Epub 2018 Mar 30.

PMID:
29605725
14.

Perioperative outcomes and survival following neoadjuvant stereotactic body radiation therapy (SBRT) versus intensity-modulated radiation therapy (IMRT) in pancreatic adenocarcinoma.

Chapman BC, Gleisner A, Rigg D, Meguid C, Goodman K, Brauer B, Gajdos C, Schulick RD, Edil BH, McCarter MD.

J Surg Oncol. 2018 Apr;117(5):1073-1083. doi: 10.1002/jso.25004. Epub 2018 Feb 15.

PMID:
29448308
15.

Newly Emerging Immune Checkpoints: Promises for Future Cancer Therapy.

Torphy RJ, Schulick RD, Zhu Y.

Int J Mol Sci. 2017 Dec 6;18(12). pii: E2642. doi: 10.3390/ijms18122642. Review.

16.

Screening of Patients at Risk for Familial Pancreatic Cancer: What Is Beneficial?

Torphy RJ, Schulick RD.

Surg Clin North Am. 2018 Feb;98(1):25-35. doi: 10.1016/j.suc.2017.09.003. Review.

PMID:
29191275
17.

Comparison of laparoscopic to open pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma.

Chapman BC, Gajdos C, Hosokawa P, Henderson W, Paniccia A, Overbey DM, Gleisner A, Schulick RD, McCarter MD, Edil BH.

Surg Endosc. 2018 May;32(5):2239-2248. doi: 10.1007/s00464-017-5915-0. Epub 2017 Oct 24.

PMID:
29067580
18.

What We Learned From John Cameron.

Schulick RD.

Ann Surg. 2018 Feb;267(2S Suppl 2):S3-S5. doi: 10.1097/SLA.0000000000002576. No abstract available.

PMID:
29064886
19.

Laparoscopic pancreaticoduodenectomy: changing the management of ampullary neoplasms.

Chapman BC, Gleisner A, Ibrahim-Zada I, Overbey DM, Paniccia A, Meguid C, Brauer B, Gajdos C, McCarter MD, Schulick RD, Edil BH.

Surg Endosc. 2018 Feb;32(2):915-922. doi: 10.1007/s00464-017-5766-8. Epub 2017 Aug 4.

PMID:
28779245
20.

Anaplastic Pancreatic Carcinoma Arising Within a Mucinous Cystic Neoplasm of the Pancreas: A Case Report and a Brief Review of the Literature.

Paniccia A, Torphy R, Devaraj K, Schulick RD.

J Pancreat Cancer. 2017 Jul 1;3(1):40-45. doi: 10.1089/pancan.2017.0004. eCollection 2017.

21.

Blockade of CD112R and TIGIT signaling sensitizes human natural killer cell functions.

Xu F, Sunderland A, Zhou Y, Schulick RD, Edil BH, Zhu Y.

Cancer Immunol Immunother. 2017 Oct;66(10):1367-1375. doi: 10.1007/s00262-017-2031-x. Epub 2017 Jun 16.

22.

Impact of neoadjuvant chemoradiation on perioperative outcomes in patients with rectal cancer.

Chapman BC, Hosokawa P, Henderson W, Paniccia A, Overbey DM, Messersmith W, Lieu C, Stiegmann GV, Schulick RD, Gajdos C.

J Surg Oncol. 2017 Jun;115(8):1033-1044. doi: 10.1002/jso.24613. Epub 2017 Mar 23.

PMID:
28334436
23.

An institutional analysis of unplanned return to the operating room to identify areas for quality improvement.

Lin Y, Meguid RA, Hosokawa PW, Henderson WG, Hammermeister KE, Schulick RD, Shelstad RC, Wild TT, McIntyre RC Jr.

Am J Surg. 2017 Jul;214(1):1-6. doi: 10.1016/j.amjsurg.2016.10.021. Epub 2016 Dec 13.

PMID:
28057294
24.

Impact of Facility Type and Surgical Volume on 10-Year Survival in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma.

Chapman BC, Paniccia A, Hosokawa PW, Henderson WG, Overbey DM, Messersmith W, McCarter MD, Gleisner A, Edil BH, Schulick RD, Gajdos C.

J Am Coll Surg. 2017 Mar;224(3):362-372. doi: 10.1016/j.jamcollsurg.2016.11.011. Epub 2016 Dec 5.

PMID:
27923615
25.

Hypermutation In Pancreatic Cancer.

Humphris JL, Patch AM, Nones K, Bailey PJ, Johns AL, McKay S, Chang DK, Miller DK, Pajic M, Kassahn KS, Quinn MC, Bruxner TJ, Christ AN, Harliwong I, Idrisoglu S, Manning S, Nourse C, Nourbakhsh E, Stone A, Wilson PJ, Anderson M, Fink JL, Holmes O, Kazakoff S, Leonard C, Newell F, Waddell N, Wood S, Mead RS, Xu Q, Wu J, Pinese M, Cowley MJ, Jones MD, Nagrial AM, Chin VT, Chantrill LA, Mawson A, Chou A, Scarlett CJ, Pinho AV, Rooman I, Giry-Laterriere M, Samra JS, Kench JG, Merrett ND, Toon CW, Epari K, Nguyen NQ, Barbour A, Zeps N, Jamieson NB, McKay CJ, Carter CR, Dickson EJ, Graham JS, Duthie F, Oien K, Hair J, Morton JP, Sansom OJ, Grützmann R, Hruban RH, Maitra A, Iacobuzio-Donahue CA, Schulick RD, Wolfgang CL, Morgan RA, Lawlor RT, Rusev B, Corbo V, Salvia R, Cataldo I, Tortora G, Tempero MA; Australian Pancreatic Cancer Genome Initiative, Hofmann O, Eshleman JR, Pilarsky C, Scarpa A, Musgrove EA, Gill AJ, Pearson JV, Grimmond SM, Waddell N, Biankin AV.

Gastroenterology. 2017 Jan;152(1):68-74.e2. doi: 10.1053/j.gastro.2016.09.060. Epub 2016 Nov 15.

PMID:
27856273
26.

Laparoscopic Spleen-Preserving Total Pancreatectomy for a Main-Duct Intraductal Papillary Mucinous Neoplasm.

Chapman BC, Paniccia A, Ryan C, Schulick RD, Edil BH.

Ann Surg Oncol. 2017 Feb;24(2):560. doi: 10.1245/s10434-016-5481-z. Epub 2016 Sep 2.

PMID:
27590330
27.

Total laparoscopic pancreaticoduodenectomy.

Paniccia A, Chapman B, Edil BH, Schulick RD.

J Vis Surg. 2016 Aug 2;2:130. doi: 10.21037/jovs.2016.07.13. eCollection 2016.

28.

The Multidisciplinary Approach to GI Cancer Results in Change of Diagnosis and Management of Patients. Multidisciplinary Care Impacts Diagnosis and Management of Patients.

Meguid C, Schulick RD, Schefter TE, Lieu CH, Boniface M, Williams N, Vogel JD, Gajdos C, McCarter M, Edil BH.

Ann Surg Oncol. 2016 Nov;23(12):3986-3990. Epub 2016 Jun 24.

PMID:
27342825
29.

Key Tenets of Effective Surgery Leadership: Perspectives From the Society of Surgical Chairs Mentorship Sessions.

Rosengart TK, Kent KC, Bland KI, Britt LD, Eberlein TJ, Gewertz BL, Hunter JG, Lillemoe KD, Pellegrini CA, Schulick RD, Stain SC, Weigel RJ.

JAMA Surg. 2016 Aug 1;151(8):768-70. doi: 10.1001/jamasurg.2016.0405.

PMID:
27096328
30.

A matched-cohort analysis of 192 pancreatic anaplastic carcinomas and 960 pancreatic adenocarcinomas: A 13-year North American experience using the National Cancer Data Base (NCDB).

Paniccia A, Hosokawa PW, Schulick RD, Henderson W, Kaplan J, Gajdos C.

Surgery. 2016 Aug;160(2):281-92. doi: 10.1016/j.surg.2016.02.025. Epub 2016 Apr 14.

PMID:
27085687
31.

Main-duct Intraductal Papillary Mucinous Neoplasm. High Cancer Risk in Duct Diameter of 5 to 9 mm.

Del Chiaro M, Schulick RD.

Ann Surg. 2017 Dec;266(6):e86. doi: 10.1097/SLA.0000000000001725. No abstract available.

PMID:
27043742
32.

Pancreatic Neuroendocrine Tumors: an Update.

Paniccia A, Edil BH, Schulick RD.

Indian J Surg. 2015 Oct;77(5):395-402. doi: 10.1007/s12262-015-1360-2. Epub 2015 Oct 13.

33.

Establishing a framework for building multidisciplinary programs.

Meguid C, Ryan CE, Edil BH, Schulick RD, Gajdos C, Boniface M, Schefter TE, Purcell WT, McCarter M.

J Multidiscip Healthc. 2015 Dec 2;8:519-26. doi: 10.2147/JMDH.S96415. eCollection 2015.

34.

Outcomes of arterial resection during pancreatectomy for tumor.

Glebova NO, Hicks CW, Tosoian JJ, Piazza KM, Abularrage CJ, Schulick RD, Wolfgang CL, Black JH 3rd.

J Vasc Surg. 2016 Mar;63(3):722-9.e1. doi: 10.1016/j.jvs.2015.09.042. Epub 2015 Nov 21.

35.

Predictors for Surgical Referral in Patients With Pancreatic Cystic Lesions Undergoing Endoscopic Ultrasound: Results From a Large Multicenter Cohort Study.

Ge PS, Gaddam S, Keach JW, Mullady D, Fukami N, Edmundowicz SA, Azar RR, Shah RJ, Murad FM, Kushnir VM, Ghassemi KF, Sedarat A, Watson RR, Amateau SK, Brauer BC, Yen RD, Hosford L, Hollander T, Donahue TR, Schulick RD, Edil BH, McCarter MD, Gajdos C, Attwell AR, Muthusamy VR, Early DS, Wani S.

Pancreas. 2016 Jan;45(1):51-7. doi: 10.1097/MPA.0000000000000386.

PMID:
26262589
36.

Suboptimal accuracy of carcinoembryonic antigen in differentiation of mucinous and nonmucinous pancreatic cysts: results of a large multicenter study.

Gaddam S, Ge PS, Keach JW, Mullady D, Fukami N, Edmundowicz SA, Azar RR, Shah RJ, Murad FM, Kushnir VM, Watson RR, Ghassemi KF, Sedarat A, Komanduri S, Jaiyeola DM, Brauer BC, Yen RD, Amateau SK, Hosford L, Hollander T, Donahue TR, Schulick RD, Edil BH, McCarter M, Gajdos C, Attwell A, Muthusamy VR, Early DS, Wani S.

Gastrointest Endosc. 2015 Dec;82(6):1060-9. doi: 10.1016/j.gie.2015.04.040. Epub 2015 Jun 12.

PMID:
26077458
37.

Characteristics of 10-Year Survivors of Pancreatic Ductal Adenocarcinoma.

Paniccia A, Hosokawa P, Henderson W, Schulick RD, Edil BH, McCarter MD, Gajdos C.

JAMA Surg. 2015 Aug;150(8):701-10. doi: 10.1001/jamasurg.2015.0668.

PMID:
26062046
38.

Technical risk factors for portal vein reconstruction thrombosis in pancreatic resection.

Glebova NO, Hicks CW, Piazza KM, Abularrage CJ, Cameron AM, Schulick RD, Wolfgang CL, Black JH 3rd.

J Vasc Surg. 2015 Aug;62(2):424-33. doi: 10.1016/j.jvs.2015.01.061. Epub 2015 May 4.

39.

Total Laparoscopic Pancreaticoduodenectomy: A Single-Institutional Experience.

Paniccia A, Schulick RD, Edil BH.

Ann Surg Oncol. 2015 Dec;22(13):4380-1. doi: 10.1245/s10434-015-4450-2. Epub 2015 Apr 18.

PMID:
25893407
40.

Challenges of minimally invasive pancreas surgery growth with such a high learning curve.

Edil BH, Schulick RD.

JAMA Surg. 2015 May;150(5):423. doi: 10.1001/jamasurg.2015.32. No abstract available.

PMID:
25760810
41.

Expression of the Novel Costimulatory Molecule B7-H5 in Pancreatic Cancer.

Byers JT, Paniccia A, Kaplan J, Koenig M, Kahn N, Wilson L, Chen L, Schulick RD, Edil BH, Zhu Y.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1574-9. doi: 10.1245/s10434-014-4293-2. Epub 2014 Dec 18.

PMID:
25519928
42.

Neoadjuvant FOLFIRINOX application in borderline resectable pancreatic adenocarcinoma: a retrospective cohort study.

Paniccia A, Edil BH, Schulick RD, Byers JT, Meguid C, Gajdos C, McCarter MD.

Medicine (Baltimore). 2014 Dec;93(27):e198. doi: 10.1097/MD.0000000000000198.

43.

PD-1/PD-L1 blockade together with vaccine therapy facilitates effector T-cell infiltration into pancreatic tumors.

Soares KC, Rucki AA, Wu AA, Olino K, Xiao Q, Chai Y, Wamwea A, Bigelow E, Lutz E, Liu L, Yao S, Anders RA, Laheru D, Wolfgang CL, Edil BH, Schulick RD, Jaffee EM, Zheng L.

J Immunother. 2015 Jan;38(1):1-11. doi: 10.1097/CJI.0000000000000062.

44.

A preclinical murine model of hepatic metastases.

Soares KC, Foley K, Olino K, Leubner A, Mayo SC, Jain A, Jaffee E, Schulick RD, Yoshimura K, Edil B, Zheng L.

J Vis Exp. 2014 Sep 27;(91):51677. doi: 10.3791/51677.

45.

Clearing common bile duct stones: one size does not fit all.

Montero P, Schulick RD.

JAMA Surg. 2014 Oct;149(10):1014. doi: 10.1001/jamasurg.2014.195. No abstract available.

PMID:
25134062
46.

Racial disparities in breast cancer: more bad news.

Murphy CD, Schulick RD.

JAMA Surg. 2014 Aug;149(8):796-7. doi: 10.1001/jamasurg.2014.44. No abstract available.

PMID:
24943995
47.

A safety and feasibility study of an allogeneic colon cancer cell vaccine administered with a granulocyte-macrophage colony stimulating factor-producing bystander cell line in patients with metastatic colorectal cancer.

Zheng L, Edil BH, Soares KC, El-Shami K, Uram JN, Judkins C, Zhang Z, Onners B, Laheru D, Pardoll D, Jaffee EM, Schulick RD.

Ann Surg Oncol. 2014 Nov;21(12):3931-7. doi: 10.1245/s10434-014-3844-x. Epub 2014 Jun 19.

48.

Bridging the gap from T to K: integrated surgical research fellowship for the next generation of surgical scientists.

Moore HB, Moore EE, Nehler MR, Cicutto LC, Bacon AW, Travis C, Schulick RD.

J Am Coll Surg. 2014 Feb;218(2):279-82. doi: 10.1016/j.jamcollsurg.2013.10.026. Epub 2013 Nov 12. Review. No abstract available.

49.

Sometimes consensus and expert opinion is the best we can do.

Schulick RD.

JAMA Surg. 2014 Jan;149(1):25. doi: 10.1001/jamasurg.2013.3987. No abstract available.

PMID:
24225739
50.

Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate.

McCall CM, Shi C, Cornish TC, Klimstra DS, Tang LH, Basturk O, Mun LJ, Ellison TA, Wolfgang CL, Choti MA, Schulick RD, Edil BH, Hruban RH.

Am J Surg Pathol. 2013 Nov;37(11):1671-7. doi: 10.1097/PAS.0000000000000089.

Supplemental Content

Loading ...
Support Center